Nanotech Firm Selecta Biosciences Nets $70M In Upsized IPO
Venture-backed nanotechnology company Selecta Biosciences Inc. raised $70 million in an upsized initial public offering on Wednesday that priced at the low end of its range, marking the first of three...To view the full article, register now.
Already a subscriber? Click here to view full article